Patent details

Basic Information

Publication number:

92202

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP058245812

Legal Status:

Invalid

Application number:

92202

First applicant's nationality:

Procedural language:

French

Marketing Authorization

Marketing Authorization Number:

EU/1/12/814 - ZALTRAP-aflibercept

Marketing Authorization Type:

Marketing Authorization Date:

05/02/2013

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Luxembourg (LU)

Dates

Filing date:

15/05/2013

First Marketing Authorization date:

05/02/2013

Grant date:

15/11/2013

Activation date:

Publication date:

15/11/2013

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

05/02/2028

SPC Extension Expiration:

05/02/2028

Rejection date:

Withdrawal date:

Owner

From:

15/05/2013

 

 

Name:

Aventis Pharma S.A.

Address:

20, avenue Raymond Aron, 92160 Antony, France (FR)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

15/05/2013

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

CHIRON-BLONDEL Marielle

Address:

France (FR)

2

Name:

FURFINE Eric

Address:

United States (US)

3

Name:

BISSERY Marie-christine

Address:

France (FR)

4

Name:

CEDARBAUM Jesse M.

Address:

United States (US)

5

Name:

VRIGNAUD Patricia

Address:

France (FR)

6

Name:

HOLASH Jocelyn

Address:

United States (US)

Publication

Bulletin

Bulletin Heading:

SPC4

Bulletin edition number:

2019/02

Publication date:

22/02/2019

Description:

Section F : Correction of granted supplementary protection certificates – I9 publication

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
15/01/2019	Outgoing Correspondence	1
06/08/2014	Incoming Correspondence (Post)	9
15/01/2019	Publication	1